Novartis

Faster track to 'megablockbuster'? Novartis' Entresto already soaring on social media
Fierce Pharma Marketing
Wed, 09/16/15 - 10:21 am
Novartis
social media
Entresto
Novartis priced Entresto on par with results, new cost watchdog says
Fierce Pharma
Mon, 09/14/15 - 06:02 pm
Novartis
Entresto
drug pricing
heart failure
Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains
Fierce Pharma
Fri, 09/11/15 - 05:53 pm
Novartis
Copaxone
MS
multiple sclerosis
biosimilars
Teva
Glatopa
Novartis CEO says diabetics' contact lens tests to start in 2016 -paper
Yahoo/Reuters
Sat, 09/5/15 - 11:13 am
Novartis
Joe Jimenez
diabetes
contact lens
Google
Sandoz: Zarxio marketing to be similar to a branded-drug launch
Fierce Pharma Marketing
Thu, 09/3/15 - 06:46 pm
Sandoz
Zarxio
biosimilars
Novartis
drug launches
Amgen
Neupogen
The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
age-related macular degeneration
Bayer
Regeneron
Ophthotech
Allergan
Novartis
Applied Genetic Technologies
Avalanche Biotechnologies
Roche
Lucentis
Eylea
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount
Yahoo/Reuters
Thu, 09/3/15 - 08:45 am
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Sandoz
Novartis team tracks remissions of 4-plus years in a pioneering CAR-T study
Fierce Biotech
Thu, 09/3/15 - 08:40 am
Novartis
CAR-T
CTL019
CLL
chronic lymphocytic leukemia
Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Novartis to Work With Amgen on Alzheimer’s and Migraine Drugs
Bloomberg
Wed, 09/2/15 - 10:18 am
Novartis
Amgen
migraines
Alzheimer's disease
R&D
CNP520
AMG 334
Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK
Fierce Pharma
Tue, 09/1/15 - 06:35 pm
Novartis
Europe
melanoma
GSK
Mekinist
Tafinlar
FDA Grants Expanded Use of Promacta for Novartis
Yahoo/24-7 Wall St
Tue, 08/25/15 - 08:30 am
FDA
Novartis
Promacta
chronic immune thrombocytopenia
ITP
Novartis snaps up MS indication for Glaxo's Arzerra
BioPharma Dive
Mon, 08/24/15 - 11:38 am
Novartis
MS
multiple sclerosis
GSK
Arzerra
Amgen: Waiting for Clarity on Generic Biotech
Barron's
Fri, 08/21/15 - 11:05 am
Amgen
generics
biosimilars
Novartis
Sandoz
Neupogen
Zarxio
Novartis Declines As Merck Wins Patent Battle
Bidness, ETC
Fri, 08/21/15 - 09:47 am
Novartis
Emend
patents
Merck
generics
GlaxoSmithKline flips an MS project to Novartis for up to $1B
Fierce Biotech
Fri, 08/21/15 - 09:29 am
GSK
Novartis
MS
multiple sclerosis
ofatumumab
Big Pharma still a big deal for NJ economy, despite cost cuts
Fierce Pharma
Wed, 08/19/15 - 12:21 pm
Big Pharma
New Jersey
JNJ
Merck
Novartis
Bristol-Myers Squibb
Sanofi
Bayer
Roche
GlaxoSmithKline Deal Unlikely To Help Novartis AG Top Oncology Sales
Bidness, ETC
Mon, 08/17/15 - 11:11 am
GSK
Novartis
Roche
oncology
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
AbbVie
Amgen
biosimilars
JNJ
Sandoz
Novartis
Humira
Neupogen
Remicade
Nuelasta
Enbrel
epoetin-alfa
GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain
Bidness, ETC
Mon, 08/10/15 - 11:23 am
GSK
Pfizer
M&A
Novartis
Roche

Pages